NEVVI Medicare utilization intelligence
or

← back

Provider profile

BLAZAR, MICHAEL M.D.

Hematology-Oncology · NPI 1962845172 · ST LOUIS PARK, MN

1
Groups
30
Codes · 2024
7,937
Disclosed services

BLAZAR, MICHAEL is a Hematology-Oncology in ST LOUIS PARK, MN, a member of 1 medical group, who billed 30 distinct codes to Medicare Part B in 2024.

Groups: PARK NICOLLET CLINIC (ST LOUIS PARK, MN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

7,937
disclosed services
30
codes billed to Medicare Part B
Prior year · CY2023 1,195 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg
J9030 Bcg live intravesical instillation, 1 mg
36415 Insertion of needle into vein for collection of blood sample
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96413 Administration of chemotherapy into vein, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
80053 Blood test, comprehensive group of blood chemicals
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
51720 Instillation of anti-cancer drug into bladder
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
36591 Collection of blood sample from implanted device
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
96523 Irrigation of implanted venous access drug delivery device
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.